345MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced solid tumors and breast cancer (BC): Results from a phase I study.
Saved in:
| Title: | 345MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced solid tumors and breast cancer (BC): Results from a phase I study. |
|---|---|
| Authors: | Lemech, C.1 (AUTHOR), Sun, Y.2 (AUTHOR), Nagrial, A.3 (AUTHOR), Wu, X.4 (AUTHOR), Morris, M.5 (AUTHOR), Ning, F.6 (AUTHOR), Yang, J.7 (AUTHOR), Pan, Y.8 (AUTHOR), Cai, J.9 (AUTHOR), Lu, P.10 (AUTHOR), Zhang, T.11 (AUTHOR), Qiu, F.12 (AUTHOR), Hu, C.13 (AUTHOR), Zhang, M.14 (AUTHOR), Liu, Z.15 (AUTHOR), Han, G.16 (AUTHOR), Nie, J.17 (AUTHOR), Teng, C.1 (AUTHOR), Zhou, H.18 (AUTHOR), Day, D.19 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS360-S360. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179691703 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 345MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced solid tumors and breast cancer (BC): Results from a phase I study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lemech%2C+C%2E%22">Lemech, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Y%2E%22">Sun, Y.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nagrial%2C+A%2E%22">Nagrial, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+X%2E%22">Wu, X.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morris%2C+M%2E%22">Morris, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ning%2C+F%2E%22">Ning, F.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+J%2E%22">Yang, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Y%2E%22">Pan, Y.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+J%2E%22">Cai, J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+P%2E%22">Lu, P.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+T%2E%22">Zhang, T.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+F%2E%22">Qiu, F.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+C%2E%22">Hu, C.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+M%2E%22">Zhang, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Z%2E%22">Liu, Z.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+G%2E%22">Han, G.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nie%2C+J%2E%22">Nie, J.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teng%2C+C%2E%22">Teng, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+H%2E%22">Zhou, H.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Day%2C+D%2E%22">Day, D.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS360-S360. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179691703 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.293 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S360 Titles: – TitleFull: 345MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced solid tumors and breast cancer (BC): Results from a phase I study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lemech, C. – PersonEntity: Name: NameFull: Sun, Y. – PersonEntity: Name: NameFull: Nagrial, A. – PersonEntity: Name: NameFull: Wu, X. – PersonEntity: Name: NameFull: Morris, M. – PersonEntity: Name: NameFull: Ning, F. – PersonEntity: Name: NameFull: Yang, J. – PersonEntity: Name: NameFull: Pan, Y. – PersonEntity: Name: NameFull: Cai, J. – PersonEntity: Name: NameFull: Lu, P. – PersonEntity: Name: NameFull: Zhang, T. – PersonEntity: Name: NameFull: Qiu, F. – PersonEntity: Name: NameFull: Hu, C. – PersonEntity: Name: NameFull: Zhang, M. – PersonEntity: Name: NameFull: Liu, Z. – PersonEntity: Name: NameFull: Han, G. – PersonEntity: Name: NameFull: Nie, J. – PersonEntity: Name: NameFull: Teng, C. – PersonEntity: Name: NameFull: Zhou, H. – PersonEntity: Name: NameFull: Day, D. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
